hit counter
Check-Cap Ltd. (CHEK) Stock News Sentiment & Price - Sentifly
CHEK - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Check-Cap Ltd. (CHEK)

Israel
Medical Laboratories & Research
NASDAQ
CHEK Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
CHEK Latest news
PennyStocks
Positive
Top Penny Stocks To Buy For Under $5 On WeBull
2021-10-20 15:58

A penny stocks list for the end of October The post Top Penny Stocks To Buy For Under $5 On WeBull appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PRNewsWire
Neutral
Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update
2021-08-05 08:30

ISFIYA, Israel, Aug. 5, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan ® , the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced financial results and provided a corporate update for the second quarter and six months ended June 30, 2021.

PennyStocks
Positive
Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist
2021-07-12 16:58

Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Pulse2
Negative
CHEK Stock Price Falls Over 10%: Why It Happened
2021-06-30 14:56

The stock price of Check Cap Ltd (NASDAQ: CHEK) fell by over 10% during intraday trading. This is why it happened.

PRNewsWire
Neutral
Check-Cap Ltd. Announces $35 Million Registered Direct Offering
2021-06-30 08:12

ISFIYA, Israel, June 30, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test, to detect polyps before they may transform into colorectal cancer (CRC), today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 25,925,926 of the Company's ordinary shares and accompanying short-term warrants to purchase up to an aggregate of 25,925,926 of the Company's ordinary shares in a registered direct offering.

PRNewsWire
Neutral
Check-Cap Reports First Quarter 2021 Financial Results and Corporate Update
2021-05-12 08:00

ISFIYA, Israel, May 12, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test, to detect polyps before they may transform into colorectal cancer(CRC), today announced financial results for the first quarter ended March 31, 2021 and provided a corporate update.

InvestorPlace
Positive
Mark a Major Medical Milestone with Check-Cap
2021-03-30 14:16

Why should you check out CHEK stock? An FDA approval, along with an impressive year-end capital position, provide a solid case for Check-Cap.

PRNewsWire
Neutral
Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results
2021-03-19 07:00

ISFIYA, Israel, March 19, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free, screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced financial results for the fourth quarter and full year ended December 31, 2020.

Pulse2
Negative
CHEK Stock Price Falls Over 10% Pre-Market: Why It Happened
2021-03-16 09:19

The stock price of Check Cap Ltd (NASDAQ: CHEK) fell by over 10% pre-market. This is why it happened.

InvestorPlace
Positive
CHEK Stock: The Big FDA News That Has Check-Cap Shares Skyrocketing Today
2021-03-15 10:21

Check-Cap (CHEK) stock is heading higher on Monday after the company announced approval from the FDA for one of its devices. The post CHEK Stock: The Big FDA News That Has Check-Cap Shares Skyrocketing Today appeared first on InvestorPlace.

Loading more news...